Editorial
Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity
Inhibidores selectivos de fosfodiesterasas, una nueva opción terapéutica en inflamación y autoinmunidad
Read
11234
Timeswas read the article
3142
Total PDF
8092
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 7 | 3 | 10 |
| 2025 5 | 227 | 48 | 275 |
| 2025 4 | 231 | 41 | 272 |
| 2025 3 | 158 | 26 | 184 |
| 2025 2 | 170 | 46 | 216 |
| 2025 1 | 137 | 49 | 186 |
| 2024 12 | 111 | 38 | 149 |
| 2024 11 | 109 | 71 | 180 |
| 2024 10 | 82 | 43 | 125 |
| 2024 9 | 90 | 41 | 131 |
| 2024 8 | 72 | 47 | 119 |
| 2024 7 | 69 | 33 | 102 |
| 2024 6 | 68 | 44 | 112 |
| 2024 5 | 71 | 60 | 131 |
| 2024 4 | 80 | 31 | 111 |
| 2024 3 | 80 | 31 | 111 |
| 2024 2 | 53 | 28 | 81 |
| 2024 1 | 50 | 34 | 84 |
| 2023 12 | 48 | 33 | 81 |
| 2023 11 | 70 | 45 | 115 |
| 2023 10 | 66 | 35 | 101 |
| 2023 9 | 112 | 42 | 154 |
| 2023 8 | 65 | 15 | 80 |
| 2023 7 | 70 | 32 | 102 |
| 2023 6 | 86 | 21 | 107 |
| 2023 5 | 67 | 28 | 95 |
| 2023 4 | 51 | 22 | 73 |
| 2023 3 | 144 | 43 | 187 |
| 2023 2 | 112 | 39 | 151 |
| 2023 1 | 88 | 38 | 126 |
| 2022 12 | 132 | 47 | 179 |
| 2022 11 | 133 | 51 | 184 |
| 2022 10 | 111 | 39 | 150 |
| 2022 9 | 96 | 53 | 149 |
| 2022 8 | 67 | 56 | 123 |
| 2022 7 | 74 | 71 | 145 |
| 2022 6 | 82 | 55 | 137 |
| 2022 5 | 70 | 75 | 145 |
| 2022 4 | 86 | 60 | 146 |
| 2022 3 | 60 | 48 | 108 |
| 2022 2 | 79 | 44 | 123 |
| 2022 1 | 145 | 69 | 214 |
| 2021 12 | 70 | 64 | 134 |
| 2021 11 | 81 | 52 | 133 |
| 2021 10 | 95 | 64 | 159 |
| 2021 9 | 81 | 49 | 130 |
| 2021 8 | 71 | 42 | 113 |
| 2021 7 | 75 | 40 | 115 |
| 2021 6 | 113 | 38 | 151 |
| 2021 5 | 204 | 61 | 265 |
| 2021 4 | 455 | 116 | 571 |
| 2021 3 | 229 | 45 | 274 |
| 2021 2 | 219 | 35 | 254 |
| 2021 1 | 193 | 40 | 233 |
| 2020 12 | 147 | 37 | 184 |
| 2020 11 | 103 | 37 | 140 |
| 2020 10 | 113 | 38 | 151 |
| 2020 9 | 70 | 37 | 107 |
| 2020 8 | 69 | 25 | 94 |
| 2020 7 | 66 | 30 | 96 |
| 2020 6 | 80 | 35 | 115 |
| 2020 5 | 91 | 22 | 113 |
| 2020 4 | 33 | 21 | 54 |
| 2020 3 | 16 | 4 | 20 |
| 2019 5 | 4 | 0 | 4 |
| 2019 1 | 1 | 0 | 1 |
| 2018 12 | 2 | 0 | 2 |
| 2018 8 | 0 | 1 | 1 |
| 2018 5 | 18 | 3 | 21 |
| 2018 4 | 123 | 5 | 128 |
| 2018 3 | 98 | 9 | 107 |
| 2018 2 | 101 | 12 | 113 |
| 2018 1 | 99 | 10 | 109 |
| 2017 12 | 76 | 14 | 90 |
| 2017 11 | 89 | 13 | 102 |
| 2017 10 | 92 | 14 | 106 |
| 2017 9 | 67 | 33 | 100 |
| 2017 8 | 51 | 15 | 66 |
| 2017 7 | 51 | 16 | 67 |
| 2017 6 | 59 | 25 | 84 |
| 2017 5 | 109 | 33 | 142 |
| 2017 4 | 68 | 32 | 100 |
| 2017 3 | 74 | 35 | 109 |
| 2017 2 | 56 | 33 | 89 |
| 2017 1 | 56 | 30 | 86 |
| 2016 12 | 71 | 57 | 128 |
| 2016 11 | 68 | 40 | 108 |
| 2016 10 | 6 | 5 | 11 |
Show all
